BioSpace News Archive

Increasing Frequency of Chronic Diseases Among Older Population is Expected to Drive Orthostatic Hypotension Market Growth by 2030 – Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Orthostatic Hypotension Market – Forecast to 2030,’ thoroughly examines the Orthostatic Hypotension industry to provide essential data & information for the targeted readers.

September 22, 2022
·
6 min read
Increase in the Number of People Adopting Unhealthy Lifestyles is Expected to Drive Urothelial Carcinoma Market Growth by 2030 – Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Urothelial Carcinoma Market – Forecast to 2030,’ thoroughly examines the Urothelial Carcinoma industry to provide essential data & information for the targeted readers.

September 22, 2022
·
5 min read
Bionics Market Size to Reach USD 18.28 billion 2025 | Emergen Research

The bionics market is projected to reach USD 18.28 billion by 2025 from an estimated USD 7.11 billion in 2020, at a CAGR of 21.4% during the forecast period, according to a latest study by Emergen Research.

September 22, 2022
·
7 min read
Biotech Bay

Slope Listed as a Sample Vendor in Gartner® Hype Cycle™ for Life Science Clinical Development, 2022 for Clinical Trial Resource Management

Slope, provider of the first eClinical Supply Chain Management (eCSCM) platform, announced that it has been identified as a Sample Vendor in the 2022 Gartner Hype Cycle for Life Science Clinical Development, 2022.

September 22, 2022
·
4 min read
Business

Maze Therapeutics Appoints Sekar Kathiresan, M.D., to its Board of Directors

Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced that Sekar Kathiresan, M.D., a Maze co-founder, has joined the company’s board of directors.

September 22, 2022
·
3 min read
Business

Horizon Therapeutics plc Expands Commitment to Education Equity, STEAM Careers and Historically Black Colleges and Universities, Adding Meharry Medical College as Horizon Scholars Partner

Horizon Therapeutics plc (Nasdaq: HZNP) today expanded its commitment to education equity, science, technology, engineering, arts and math (STEAM) careers and historically Black colleges and universities (HBCUs) through its Horizon Scholars program.

September 22, 2022
·
3 min read
Biotech Beach

Ensysce Biosciences Announces Initiation of Second Human Abuse Potential Study, Being Conducted by DVCR

Ensysce Biosciences, Inc. today announced the initiation of PF614-104, ‘A Randomized, Double-blind, Placebo and Active-Controlled, Crossover Study to Evaluate the Oral Abuse Potential of PF614 Compared with Oxycodone Immediate-Release Tablets, and Placebo in Non-Dependent Recreational Opioid Users.’

September 22, 2022
·
5 min read
Business

Metagenomi Named an Endpoints 11 Winner

Metagenomi, a genetic medicines company with a versatile portfolio of wholly-owned, next-generation gene editing tools, today announced that it was selected as one of this year’s 11 most promising private biotechnology companies by John Carroll, founder and editor of Endpoints News.

September 22, 2022
·
2 min read
BioForest

Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome

Clearmind Medicine Inc. (CSE: CMND), (OTC Pink: CMNDF), (FSE: CWY0) (“Clearmind” or the “Company”) today announced it has filed a provisional patent application related to metabolic syndromes including obesity.

September 22, 2022
·
4 min read
Business

Celsius Therapeutics Names Scientific Advisers

Celsius Therapeutics, a biotechnology company pioneering new precision medicines for patients with cancer and autoimmune disease by harnessing the power of single-cell RNA sequencing and human biology at scale, today announced the appointments of six scientific advisers.

September 22, 2022
·
3 min read